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Abstract. 
 
Chondroadherin (the 36-kD protein) is a leu-
cine-rich, cartilage matrix protein known to mediate 
adhesion of isolated chondrocytes. In the present study 
we investigated cell surface proteins involved in the in-
teraction of cells with chondroadherin in cell adhesion 
and by affinity purification. Adhesion of bovine articu-
lar chondrocytes to chondroadherin-coated dishes was 
 
dependent on Mg
 
2
 
1
 
 or Mn
 
2
 
1
 
 but not Ca
 
2
 
1
 
. Adhesion 
was partially inhibited by an antibody recognizing 
 
b
 
1 
integrin subunit. Chondroadherin-binding proteins 
from chondrocyte lysates were affinity purified on 
chondroadherin-Sepharose. The 
 
b
 
1 integrin antibody 
immunoprecipitated two proteins with molecular mass 
 
z
 
110 and 140 kD (nonreduced) from the EDTA-eluted 
material. These results indicate that a 
 
b
 
1 integrin on 
chondrocytes interacts with chondroadherin. To iden-
tify the 
 
a
 
 integrin subunit(s) involved in interaction of 
cells with the protein, we affinity purified chondroad-
herin-binding membrane proteins from human fibro-
blasts. Immunoprecipitation of the EDTA-eluted mate-
rial from the affinity column identified 
 
a
 
2
 
b
 
1 as a 
chondroadherin-binding integrin. These results are in 
agreement with cell adhesion experiments where anti-
bodies against the integrin subunit 
 
a
 
2 partially inhib-
ited adhesion of human fibroblast and human chondro-
cytes to chondroadherin. Since 
 
a
 
2
 
b
 
1 also is a receptor 
for collagen type II, we tested the ability of different 
antibodies against the 
 
a
 
2 subunit to inhibit adhesion of 
T47D cells to collagen type II and chondroadherin. The 
results suggested that adhesion to collagen type II and 
chondroadherin involves similar or nearby sites on the 
 
a
 
2
 
b
 
1 integrin. Although 
 
a
 
2
 
b
 
1 is a receptor for both 
collagen type II and chondroadherin, only adhesion of 
cells to collagen type II was found to mediate spreading.
 
Please address all correspondence to Dr. Evy Lundgren-Åkerlund, De-
partment of Cell and Molecular Biology, Section for Connective Tissue
Biology, Lund University, P.O. Box 94, S-221 00 Lund, Sweden. Tel.: (46)
46-222-3311; FAX: (46) 46-211-3417.
 
1. 
 
Abbreviation used in this paper
 
: CHAD, chondroadherin. 
 
T
 
he 
 
cartilage extracellular matrix is highly special-
ized in its composition and organization to adapt to
and withstand mechanical forces. A number of the
matrix molecules are found predominantly or exclusively
in cartilage (20). The major matrix components are col-
lagens and proteoglycans (19), with collagen type II repre-
senting 
 
z
 
95% of the collagens (11) and aggrecan 
 
z
 
95% of
the proteoglycans (16). Collagen type II fibers provide
tensile strength to the tissue, whereas aggrecan, bound to
hyaluronan, provides resilience. The interplay between
these molecules is essential for cartilage function (33).
Several other matrix components are involved in main-
taining the specific cartilage properties, where some have
primarily structural roles and others are associated with
the chondrocytes and are likely to be involved in monitor-
ing matrix properties and mediating signals to the cells
(20). The chondrocytes, being the only type of cell in carti-
lage, have a key function in cartilage homeostasis. Their
roles include controlling normal turnover of matrix mole-
cules, depositing molecules into a functioning matrix, and
responding to alterations in load with appropriate remod-
eling.
Chondroadherin (CHAD)
 
1
 
, originally described as a 36-
kD protein, is a prominent noncollagenous extracellular
protein in cartilage (31). Although the protein has been
detected in extracts from cartilage and bone (31), recent
data show very low expression of CHAD mRNA in bone
while it is prominently expressed in certain zones of carti-
lage in young rats (Shen, Z., D. Heinegård, and Y. Som-
marin, unpublished results). CHAD contains only a short
oligosaccaride lacking sialic acid and hexosamines on
serine 122 (31, 35). More recently its sequence was deter-
mined, both at the protein and cDNA level, showing that
CHAD is a unique member of the leucine-rich repeat
(LRR) protein family (35). Other members of this diverse
family include the small cartilage proteoglycans biglycan
(12), decorin (28), fibromodulin (36), lumican (2), and
keratocan (6), as well as PRELP (1).
It has been shown earlier that isolated chondrocytes ad-
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here to chondroadherin immobilized on plastic culture
dishes (44) indicating that one function of this protein is to
mediate interactions between the chondrocytes and the
extracellular matrix. Fibroblasts and osteoblasts also ad-
hered to CHAD (44), suggesting that a cell surface protein
common to several cell types may be the receptor for the
protein.
Integrins, a family of membrane glycoproteins, are of
prime importance for adhesion of most cells to extracellu-
lar matrix proteins (22, 25, 37). They consist of two sub-
units, 
 
a
 
 and 
 
b
 
, where the extracellular domain of the 
 
a
 
subunits has several divalent, cation-binding sites. The in-
tegrins 
 
a
 
1
 
b
 
1, 
 
a
 
2
 
b
 
1, 
 
a
 
3
 
b
 
1, 
 
a
 
5
 
b
 
1, and 
 
a
 
6
 
b
 
1 
 
a
 
v
 
b
 
3 and 
 
a
 
v
 
b
 
5
have been found on chondrocytes (8, 50; Holmvall, K., L.
Camper, and E. Lundgren-Åkerlund, unpublished results),
but their ligands in cartilage have not been fully defined. In-
tegrins 
 
a
 
1
 
b
 
1 and 
 
a
 
2
 
b
 
1 have been found to mediate binding
to collagen type II (8, 24) and 
 
a
 
5
 
b
 
1 mediates binding to fi-
bronectin (38). In the present study we investigated the in-
teraction of cells with the cartilage matrix protein CHAD to
identify the cellular receptor that is involved.
 
Materials and Methods
 
Antibodies
 
Monoclonal antibodies against the human integrin subunits 
 
b
 
1 (P4C10),
 
a
 
2 (P1E6), 
 
a
 
3 (P1B5), 
 
a
 
5 (P1D6), and 
 
a
 
v (VNR147) (unpurified ascites
fluid) were from Life Technologies Inc. (Grand Island, NY). Monoclonal
antibody against the human integrin 
 
b
 
3 (RUU-PLF12, purified IgG) were
purchased from Becton Dickinson (Bedford, MA). Monoclonal antibod-
ies against the human integrins 
 
a
 
v
 
b
 
5 (P1F6) and 
 
a
 
v
 
b
 
3 (LM609) (purified
IgG) were from Chemicon International, Inc. (Temecula, CA). The mono-
clonal antibodies against the human integrin subunits 
 
a
 
1 (TS2/7; hybri-
doma supernatant) and 
 
a
 
2 (P1H5; hybridoma supernatant) and rabbit
polyclonal antibodies against rat 
 
b
 
1 integrin were kind gifts from Drs.
William Carter, (Fred Hutchinson Cancer Research Center, Seattle, WA;
3), Timothy Springer (Boston Blood Center, Boston, MA; 23), and
Kristofer Rubin (Uppsala University, Uppsala, Sweden; 15), respectively.
The monoclonal antibodies Gi9, Gi14, Gi19, and Gi26 (hybridoma super-
natant), recognizing human 
 
a
 
2 integrin subunit, were kind gifts from Dr.
Sentot Santoso (Justus-Liebig University, Giessen, Germany; 39).
 
Cell Isolation and Culture
 
Bovine chondrocytes were isolated by collagenase (CLS1; Worthington
Biochemical Corp., Lakewood, NJ) digestion of articular cartilage from
4–6-month old calves as described elsewhere (43). Briefly, cartilage slices
were digested by collagenase in EBSS (Earle’s balanced salt solution;
GIBCO BRL, Gaithersburg, MD) for 15–16 h at 37
 
8
 
C. The cells were fil-
tered through a 100 
 
m
 
m nylon filter, washed three times in Dulbecco’s
modified PBS (GIBCO BRL), and used immediately after isolation. Hu-
man chondrocytes from knee joint cartilage were isolated by pronase
(Calbiochem, La Jolla, CA) digestion for 1 h followed by collagenase
(Boehringer Mannheim, Indianapolis, IN) digestion for 15–18 h as de-
scribed by Häuselmann et al. (17). The cells were filtered and washed as
described above. Human lung carcinoma fibroblasts (A549) and human
mammary tumor cells (T47D) obtained from the American Type Culture
Collection (Rockville, MD) were cultured in Dulbecco’s minimal essential
medium (DMEM) supplemented with 10% fetal calf serum, 50 UI penicil-
lin, and 50 
 
m
 
g/ml streptomycin (GIBCO BRL). Human chondrocytes
were cultured in DMEM and F12 (1:1) supplemented with 10% fetal calf
serum, 25 
 
m
 
g/ml ascorbic acid, 50 UI penicillin, and 50 
 
m
 
g/ml streptomycin
(GIBCO BRL). To harvest cells, the culture dish was washed three times
with Ca/Mg-free PBS, and the cells were incubated with 0.5% trypsin and
1 mM EDTA (GIBCO BRL) in PBS (
 
2
 
Ca and Mg) for 5 min. Detached
cells were suspended in medium containing 10% FCS or in PBS contain-
ing 1 mg/ml trypsin inhibitor (Sigma Chemical Co., St. Louis, MO) and
then washed in PBS.
 
Cell Adhesion
 
Tissue culture-treated, 48-well dishes (Nunclon, Nunc, Denmark) were
coated overnight at room temperature with 5 or 10 
 
m
 
g/ml CHAD in 4M
guanidine-HCl, 50 mM Tris-HCl, pH 7.6, or 10 
 
m
 
g/ml collagen type II
(CII) in PBS and blocked with 0.25% BSA (Serva Feinbiochemica, Wich-
ita Falls, TX; Sigma Chemical Co.) in PBS. Collagen type II was isolated
from nasal cartilage by pepsin digestion (34). The dishes were rinsed four
times with PBS before the experiment. When the effects of divalent cat-
ions were studied, the cells were washed three times in Ca/Mg-free PBS
and resuspended in the same buffer supplemented either with 1 mM CaCl
 
2
 
, 1
mM MgCl
 
2
 
, 50 
 
m
 
M MnCl
 
2
 
, 1 mM of both CaCl
 
2
 
 and MgCl
 
2
 
 or supple-
mented with all the divalent cations. The cells suspended in PBS contain-
ing 0.1% BSA were added to the wells at a concentration of 100,000/well
of bovine chondrocytes and 50,000/well of human chondrocytes, A549, or
T47D-cells. Cells were allowed to adhere for 1 h at 37
 
8
 
C. When the effect
of antibodies on adhesion was investigated, the cells were suspended in
PBS (
 
1
 
Ca and Mg) and incubated with antibodies for 20 min at room
temperature before plating of the cells. The monoclonal antibodies 
 
b
 
1, 
 
a
 
2
(P1E6), 
 
a
 
3, 
 
a
 
5, 
 
a
 
v, and 
 
a
 
v
 
b
 
5 (unpurified ascites fluid) were diluted 1:100,
P1H5 (hybridoma supernatant) was diluted 1:25, and Gi9, Gi14, Gi19, and
Gi26 (hybridoma supernatant) were diluted 1:10. The monoclonal anti-
bodies 
 
b
 
3 and 
 
a
 
v
 
b
 
3 were used at a concentration of 10 
 
m
 
g/ml. After 1 h of
incubation the wells were gently rinsed with PBS to remove nonadherent
cells. Adhesion was determined by measuring lysosomal hexosaminidase
as described by Landegren (29).
 
Cell Spreading
 
Chamber slides (8 chamber; Lab-Tek
 
®
 
, Nunc Inc., Naperville, IL) were
coated with 5 
 
m
 
g/ml of CHAD in 4M guanidine-HCl, 50 mM Tris-HCl, pH
7.5, or 5 
 
m
 
g/ml of collagen type II in PBS and blocked with 0.25% BSA in
PBS. T47D-cells (20,000/well) were added to the chambers, allowed to ad-
here, and spread for 3 h at 37
 
8
 
C in the absence or in the presence of
10
 
2
 
8
 
  M phorbol 12-myristate 13-acetate (PMA; Sigma Chemical Co.).
Nonadherent cells were removed by washing, and the adherent cells were
fixed with 2% paraformaldehyde in PBS and stained with Mayers’s hema-
toxylin and 0.3% erythrosin. Spreading was visualized by light micros-
copy, and mean cell area was calculated by image analysis using the Zeiss
Software KS400/V2.00 (Zeiss, Inc., Oberkochen, Germany).
 
Surface Labeling with 
 
125
 
I
 
Bovine chondrocytes or human lung carcinoma fibroblasts A549 were sus-
pended in 1 ml of PBS containing 1 mg/ml glucose. 
 
125
 
I (1 mCi; Nordion
Inc., Kanata, ON, Canada) was added to the cells together with 4 U of lac-
toperoxidase (Sigma Chemical Co.; 120 U/mg) and 0.05 U of glucose oxi-
dase (Sigma Chemical Co.; 1010 U/ml) prepared fresh in PBS-glucose.
The cells were kept on ice for 15 min, whereafter the reaction was stopped
by adding 10 ml of Dulbecco’s culture medium. The cells were then
washed three times with PBS and lysed for 1h on ice in 2 ml of 1% Triton
X-100, 100 
 
m
 
g/ml aprotinin, 2 
 
m
 
g/ml leupeptin, 2 
 
m
 
g/ml pepstatin A, 1 mM
PMSF (Sigma Chemical Co.), 1 mM MnCl
 
2
 
, 1 mM MgCl
 
2
 
 in 10 mM Tris-
HCl, pH 7.4. Cell lysates were centrifuged at 10,000 rpm for 30 min at 4
 
8
 
C,
and the pellets were discarded.
 
Isolation and Coupling of CHAD to Agarose
 
CHAD was purified from bovine tracheal cartilage essentially according
to the published procedure (31). For coupling, CHAD (2.5 mg) was solu-
bilized in 0.5% SDS and coupled to 2 ml of Mini-Leak agarose (Biocarb
Chemicals, Lund, Sweden) according to the manufacturer’s instructions.
The control agarose was treated in a similar manner but in the absence of
protein.
 
Affinity Purification of CHAD-binding Protein
 
The CHAD agarose (0.5 ml) and the control agarose (0.5 ml) were packed
in mini-columns (Bio Rad, Hercules, CA) and equilibrated with at least 20
vol of 0.1% Triton X-100, 10 mM Tris-HCl, pH 7.4, 1 mM MnCl
 
2
 
, and 1 mM
MgCl
 
2
 
. The lysates from the 
 
125
 
I-labeled cells were passed over the control
agarose two times and then incubated with the CHAD agarose in the
mini-columns for 2–3 h with continuous end-over-end mixing. The CHAD
agarose was washed with 15 vol of the equilibration buffer containing 75
mM NaCl, and the column was then eluted with 20 mM EDTA, 1 mM
PMSF, 10 mM Tris-HCl, pH 7.4. The eluted protein peak was passed over 
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a desalting column (PD-10; Pharmacia Fine Chemicals, Uppsala, Sweden)
equilibrated with 50 mM Tris, pH 7.4, 0.3 M NaCl, 1% Triton X-100, 0.1%
BSA, 1 mM CaCl
 
2
 
, 1 mM MgCl
 
2
 
, and 1 mM PMSF. Samples of the affin-
ity-purified proteins were then either precipitated by methanol/chloro-
form (48) or immunoprecipitated by antibodies followed by separation on
4–12% SDS-PAGE and visualized by autoradiography or image analysis
using the BioImaging Analyzer Bas2000 (Fuji Photo Film Co., Tokyo,
Japan).
 
Immunoprecipitation
 
Radiolabeled proteins were immunoprecipitated from cell lysate and from
affinity-purified material. In experiments where lysates were immunopre-
cipitated they were passed over a desalting column (PD-10; Pharmacia
Fine Chemicals) equilibrated and eluted with 50 mM Tris, pH 7.4, 0.3 M
NaCl, 1% Triton X-100, 0.1% BSA, 1 mM CaCl
 
2
 
, 1 mM MgCl
 
2
 
, 1 mM
PMSF. The cell lysate or the affinity-purified samples were incubated with
continuous end-over-end mixing overnight with 5 
 
m
 
l/ml of monoclonal an-
tibodies (
 
b
 
1, 
 
b3, a1, a2 (P1E6), a3, a5, av, and avb5) or 50 mg/ml of the
polyclonal antibody (b1) followed by addition of 75 ml anti–mouse IgG-
agarose (Sigma Chemical Co.) or 100 ml protein A-Sepharose (Pharmacia
Fine Chemicals) and incubation for 2 h. The beads were centrifuged for 4
min at 4,000 rpm, washed three times with 1% Triton X-100, 0.5 M NaCl,
and 10 mM Tris-HCl, pH 7.4. All steps were performed at 48C. SDS-
PAGE sample buffer (100 ml) was added to the washed immunoprecipi-
tates, and the samples were boiled for 5 min with or without 2-mercap-
toethanol (5%). The immunoprecipitated proteins were separated by
SDS-PAGE (4–12%) and visualized by autoradiography or by using the
phosphoimager. 
Statistics
Results are presented as means 6 SD. Student’s t test was used to deter-
mine statistical significance.
Results
Adhesion of Cells to Chondroadherin
CHAD, immobilized on culture dishes, mediated adhesion
of cells in a dose-dependent manner (Fig. 1). Maximal ad-
hesion was seen at a coating concentration of 1.2 mg/ml.
Adhesion of bovine chondrocytes to CHAD was depen-
dent on divalent cations such that Mg21 or Mn21 but not
Ca21 was required (Fig. 2). Only a low number of cells ad-
hered to the control BSA (Fig. 2). The adhesion to CHAD
decreased by 2/3 in the presence of 100 mg/ml of a poly-
clonal rat b1 integrin antibody compared to adhesion in
the absence of antibody (Fig. 3). This indicated that b1 in-
tegrins are involved in the adhesion of chondrocytes to
CHAD. The control antibody had only a minor effect on
the adhesion.
Figure 1. Adhesion of T47D cells to dishes coated with CHAD.
Culture dishes (48 well) were coated with various concentrations
of CHAD and blocked for nonspecific binding with BSA
(0.25%). T47D cells (50,000/well) were allowed to adhere for 1 h
at 378C. Nonadherent cells were removed by washing, and adhe-
sion was determined by analyzing lysosomal hexosaminidase.
The results presented are the mean adhesion in duplicates from
one of two experiments.
Figure 2. Divalent cation-dependent adhesion of chondrocytes to
CHAD. Culture dishes (48 well) were coated with CHAD (5 mg/
ml) and blocked for nonspecific binding with BSA (0.25%). Bo-
vine chondrocytes were allowed to adhere to the dishes for 1 h at
378C in the absence of divalent cations or in the presence of Ca21
(1 mM), Mg21 (1 mM), or Mn21 (50 mM). Nonadherent cells were
removed by washing, and adhesion was determined by analyzing
lysosomal hexosaminidase. Adhesion is expressed as a percent-
age of the total number of cells added to the dish. The numbers
represent the mean adhesion from three wells 6SD from one of
three experiments.
Figure 3. b1 integrin-dependent adhesion of chondrocytes to
CHAD. Culture dishes (48 well) were coated overnight with
chondroadherin (5 mg/ml) and blocked for nonspecific binding
with BSA (0.25%). Bovine chondrocytes were allowed to adhere
to the dishes for 1 h at 378C in the presence of various concentra-
tions of a polyclonal antibody against the rat b1 integrin subunit
or control IgG. Nonadherent cells were removed by washing, and
adhesion was determined by analyzing lysosomal hexosamini-
dase. The adhesion is expressed as a percentage of the control,
and the numbers represent mean of duplicate adhesion from one
of three experiments.The Journal of Cell Biology, Volume 138, 1997 1162
Affinity Chromatography of CHAD-binding Cell 
Surface Proteins
To identify integrins with affinity for CHAD, Triton X-100–
solubilized,  125I-labeled cell surface proteins from bovine
chondrocytes were affinity purified on CHAD coupled to
agarose. As shown in Fig. 4, two proteins with molecular
weight z110 and 140 kD (nonreduced) were eluted from
the CHAD column with EDTA. These proteins were im-
munoprecipitated with a polyclonal antibody against b1
integrin. As shown in the figure, this b1 integrin showed
two bands migrating corresponding to 120 (b1 chain) and
150 kD (a chain) upon SDS-PAGE under reducing condi-
tions. In addition, a protein band with mobility corre-
sponding to 100 kD was found, which may represent a deg-
radation product of the b1 integrin. We were not able to
further identify the a chain from the chondrocyte integrin,
since available antibodies against human integrins showed
too low cross-reactivity to bovine integrins. To identify the
b1-associated  a chain with affinity for CHAD, Triton
X-100–solubilized,  125I-labeled cell surface proteins from
human fibroblasts were affinity purified on the CHAD
column. Proteins eluted from the CHAD affinity purifica-
tion experiments were immunoprecipitated with mono-
clonal antibodies against the human integrin subunits b1,
a1, a2, a5, and av. Fig. 5 shows that the antibodies against
the integrin subunits b1 and a2 immunoprecipitated an in-
tegrin dimer of similar appearance, while antibodies against
a1, a5, and av did not specifically immunoprecipitate inte-
grins from the EDTA eluate. In a control experiment (Fig.
6) it was shown that these cells express a number of differ-
ent integrins. Taken together, these results strongly indi-
cate that the integrin a2b1 is a receptor for CHAD.
Inhibition of Cell Adhesion to CHAD by
Integrin Antibodies
Fibroblasts were adhered to CHAD in cell adhesion ex-
periments in the presence of antibodies against various in-
tegrin subunits. As shown in Fig. 7 antibodies against the
a2 or b1 integrin subunits inhibited the cell adhesion to
.50% while antibodies against b3, a5, av, avb3, or avb5
had no or only a minor effect on the adhesion. In contrast
to the other antibodies, the a3 antibody stimulated the ad-
hesion of fibroblasts to CHAD. In agreement with the af-
finity purification experiments, these results show that
a2b1 is a CHAD-binding integrin.
To study whether a2b1 is involved in the adhesion of
chondrocytes to CHAD, human chondrocytes were ad-
hered to immobilized CHAD in the absence or in the pres-
ence of an antibody against the integrin subunit a2. The
antibody partially inhibited the adhesion of chondrocytes
in a dose-dependent manner (Fig. 8). Around 30% of the
adhesion was inhibited at the highest antibody concentra-
tion. This result confirmed that a2b1 is a CHAD-binding
integrin on chondrocytes.
Since a2b1 is a receptor for both collagen type II (24)
and CHAD, we investigated the interaction of T47D-cells
(cells that express the a2 but not the a1 subunit) with
these two substrates, using various antibodies to the a2 in-
tegrin subunit (Fig. 9). The a2 antibodies inhibited cell ad-
hesion to collagen type II and CHAD in a similar manner,
although they were somewhat less effective in the CHAD
experiment. Higher concentrations of the antibodies did
Figure 4. Affinity purification of
CHAD-binding cell surface pro-
teins. Bovine chondrocytes were
125I-labeled and lysed with 1% Tri-
ton X-100, 100 mg/ml aprotinin, 2
mg/ml leupeptin, 2 mg/ml pepstatin
A, 1 mM PMSF, 1 mM MnCl2, and
1 mM MgCl2 in 10 mM Tris-HCl,
pH 7.4. The lysate was passed over
control agarose followed by CHAD
agarose. Proteins with affinity for
CHAD were eluted by EDTA (20
mM), passed over a desalting col-
umn (PD-10) equilibrated, and
eluted with 0.3 M NaCl, 1% Triton
X-100, 0.1% BSA 1 mM CaCl2, 1
mM MgCl2, 1 mM PMSF, in 50 mM
Tris-HCl, pH 7.4. An aliquot of the
protein peak was immunoprecipitated with the polyclonal rat b1
integrin antibody. Proteins in the eluate (E) and in the immuno-
precipitate (b1) were separated by 4–12% SDS-PAGE under re-
ducing (R) or nonreducing (NR) conditions.
Figure 5. Immunoprecipitation of CHAD-binding integrins from
human fibroblasts. 125I-labeled A549 fibroblasts were lysed with
1% Triton X-100, 100 mg/ml aprotinin, 2 mg/ml leupeptin, 2 mg/ml
pepstatin A, 1 mM PMSF, 1 mM MnCl2, and 1 mM MgCl2 in 10
mM Tris-HCl, pH 7.4. The lysate was passed over control agarose
followed by CHAD agarose. Proteins with affinity for CHAD
were eluted by EDTA (20 mM), passed over a desalting column
(PD-10) equilibrated, and eluted with 0.3 M NaCl, 1% Triton
X-100,  0.1% BSA, 1 mM CaCl2, 1 mM MgCl2, 1 mM PMSF in 50
mM Tris-HCl, pH 7.4. Aliquots of the protein peak were immu-
noprecipitated with monoclonal antibodies against the integrin
subunits b1 (P4C10), a1 (TS2/7), a2 (P1E6), a5 (P1D6), and av
(VNR147). The immunoprecipitated proteins were separated by
SDS-PAGE (4–12%) under nonreducing conditions and visual-
ized by autoradiography.Camper et al. Integrin a2b1 Is a Receptor for Chondroadherin 1163
not change the inhibition pattern (data not shown). This
indicates that similar or nearby sites on the a2b1 integrin
are binding to the two substrates.
Spreading of Cells on Collagen Type II or CHAD
It has earlier been shown (44) that chondrocytes adhered
to CHAD appeared to stay round, while chondrocytes im-
mobilized on collagen type II spread on the substratum.
We found, similarly, that T47D cells (Fig. 10 and Table I)
and fibroblasts (data not shown) spread when they were
adhered to collagen type II but not to CHAD. The aver-
age cell area of T47D cells that were adhered to CHAD
for 3 h was z2/3 of those adhered to collagen type II (Ta-
ble I). Addition of PMA (1028 M) to the adhered cells
stimulated spreading and increased the cell area with
z40% on both CHAD and collagen type II (Fig. 10 and
Table I).
Discussion
In the present investigation we show that CHAD, a rela-
tively abundant noncollagenous protein in cartilage extra-
cellular matrix, interacts with b1 integrins on bovine chon-
drocytes. This interesting finding identifies CHAD as a
candidate for mediating signals between the chondrocytes
and the cartilage matrix.
CHAD is a member of the LRR protein family (35).
Among other members in this family are the small carti-
lage proteoglycans biglycan, decorin, fibromodulin, and
lumican. These proteoglycans are all known to interact
with collagen (18, 41, 47), but it is not known if CHAD in-
teracts with collagen or other matrix molecules.
Chondrocyte adhesion to CHAD was partially inhibited
by a rat polyclonal antibody against b1 integrin. Species
differences between cells and antibodies may explain why
the inhibition was not total. Alternatively, other receptors
than b1 integrins may also be involved in the adhesion to
CHAD. We found that adhesion of chondrocytes to
CHAD was dependent on Mg21 or Mn21 but not on Ca21.
This is consistent with results from extensive studies of
Figure 7. Inhibition of fibroblast adhesion to CHAD by integrin
antibodies. Culture dishes (48 well) were coated with CHAD (5
mg/ml) and blocked for nonspecific binding with BSA (0.25%).
Human A549 fibroblasts were allowed to adhere to the dishes for
1 h at 378C in the presence of monoclonal antibodies against the
human integrin subunits b1 (P4C10), b3 (RUU-PLF12), a2
(Gi9),  a3 (P1B5), a5 (P1D6), av (VNR147), avb3 (LM609), and
avb5 (P1F6). Nonadherent cells were removed by washing, and
adhesion was determined by analyzing lysosomal hexosamini-
dase. The adhesion is expressed as a percentage of the control,
and the numbers represent the mean of duplicate adhesion from
three individual experiments 6SD. *P , 0.05; **P , 0.01; Pb1 5
0.002; Pa2 5 0.011; Pa3 5 0.021.
Figure 6. Immunoprecipitation of integrins from human fibro-
blasts. 125I-labeled A549 fibroblasts were lysed with 1% Triton
X-100, 100 mg/ml aprotinin, 2 mg/ml leupeptin, 2 mg/ml pepstatin
A, 1 mM PMSF, 1 mM MnCl2, and 1 mM MgCl2 in 10 mM Tris-
HCl, pH 7.4. Aliquots of the lysate were immunoprecipitated
with monoclonal antibodies against the integrin subunits b1
(P4C10),  b3 (RUU-PLF12), a1 (TS2/7), a2 (P1E6), a3 (P1B5),
a5 (P1D6), av (VNR147), and avb5 (P1F6). The immunoprecipi-
tated proteins were separated by SDS-PAGE (4–12%) under
nonreducing conditions and visualized by autoradiography.
Figure 8. Inhibition of human chondrocyte adhesion to CHAD
by a2 integrin antibodies. Culture dishes (48 well) were coated
with CHAD (5 mg/ml) and blocked for nonspecific binding with
BSA (0.25%). Human chondrocytes were allowed to adhere to
the dishes for 1 h at 378C in the presence of various concentra-
tions of the monoclonal antibody against the human integrin sub-
unit a2 (Gi9). Nonadherent cells were removed by washing, and
adhesion was determined by analyzing lysosomal hexosamini-
dase. The adhesion is expressed as a percentage of the control,
and the numbers represent the mean adhesion 6SD from three
wells in one of two experiments.The Journal of Cell Biology, Volume 138, 1997 1164
Figure 9. Inhibition of adhesion of T47D cells to CHAD (a) and to collagen type II (CII; b) by various a2 antibodies. Culture dishes (48
wells) were coated with 5 mg/ml of CHAD or CII and blocked for nonspecific binding with BSA (0.25%). T47D cells were allowed to
adhere to the dishes for 1 h at 378C in the absence or in the presence of monoclonal antibodies against the integrin subunits b1 (P4C10),
b3 (RUU-PLF12), or various a2 antibodies. Nonadherent cells were removed by washing, and adhesion was determined by analyzing
lysosomal hexosaminidase. The adhesion is expressed as a percentage of the control, and the numbers represent the mean of duplicate
adhesion from three individual experiments 6SD. *P , 0.05; **P , 0.01; (a) Pb1 5 0.004; PGi9 5 0.006; PGi19 5 0.026. (b) Pb1 5 0.000;
PP1E6 5 0.001; PP1H5 5 0.001; PGi9 5 0.000; PGi26 5 0.047.
Figure 10. Spreading of T47D
cells on collagen type II (CII)
or CHAD. Chamber slides
(eight chambers) were coated
with 5 mg/ml of CII (A and
B) or CHAD (C and D) and
blocked for nonspecific bind-
ing with BSA (0.25%). Hu-
man T47D cells (20,000/
well) were plated onto the
chambers and allowed to ad-
here and spread for 3 h at
378C in the absence (A and
C) or in the presence (B and
D) of 1028 M PMA. Nonad-
herent cells were removed by
washing, and the adherent
cells were fixed with 2%
paraformaldehyde in PBS
and stained with Meyer’s he-
matoxilin and erythrosin.
Spreading was visualized by
light microscopy, and mean
cell area (Table I) was calcu-
lated by image analyses using
the Zeiss software KS400/
V2.00.Camper et al. Integrin a2b1 Is a Receptor for Chondroadherin 1165
regulation of integrin activity by divalent cations. The ac-
tivity of several integrins, including a2b1, is stimulated by
Mg21 or Mn21 and inhibited by Ca21 (14).
Available antibodies did not immunoprecipitate the b1-
associated a integrin subunit from bovine chondrocytes
that mediated the adhesion to CHAD. The most likely ex-
planation for this is that antibodies raised against human
integrin subunits show weak or no cross-reactivity to many
of the bovine chondrocyte integrins. From the molecular
weight of the CHAD-binding a integrin subunit (140 kD
nonreduced and 150 kD reduced), the fact that the appar-
ent size increased upon reduction and that the adhesion
was Mg21 dependent, it is likely that the a subunit in-
volved is a2. Since we know from FACS® analysis that iso-
lated human primary chondrocytes from articular cartilage
have relatively small amounts of the a2b1 integrin (Holm-
vall, K., L. Camper, and E. Lundgren-Åkerlund, unpub-
lished results), we chose to investigate CHAD-binding in-
tegrins on human fibroblasts. These cells express a2b1 as
well as other integrins (Fig. 6). In affinity purification ex-
periments we were able to show that the integrin a2b1 in-
deed is a CHAD-binding integrin. Antibodies against a5
and av immunoprecipitated orders of magnitude–lower
amounts of their respective integrins from the CHAD-
agarose eluate. We further found that monoclonal anti-
bodies against the subunits b1 or a2 inhibited the adhesion
of cells to culture dishes coated with CHAD, while anti-
bodies against the other integrin subunits had minor or no
effect on the adhesion. In contrast to the lack of effects of
the other integrin antibodies, the a3-integrin antibody ap-
peared to stimulate the adhesion to CHAD. The findings
corroborated further that the integrin a2b1 mediates the
interaction between cells and CHAD. To confirm a partic-
ipation of a2b1 integrins also in chondrocyte adhesion, we
studied the adhesion of human chondrocytes to CHAD in
the presence of the a2 antibody Gi9. We found that the
antibody partially inhibited adhesion of cultured chondro-
cytes to CHAD (Fig. 8), which confirms that the integrin
a2b1 indeed is involved in adhesion of chondrocytes to
this substrate. In agreement with the fibroblast experiment
the Gi9 antibody only partially inhibited the adhesion of
human chondrocytes. This may indicate that another re-
ceptor in addition to a2b1 is involved in the adhesion of
cells to CHAD. It is also possible that the immobilized
CHAD mediate a high degree of nonspecific binding.
In previous experiments, it has been shown that adhe-
sion of chondrocytes and chondrosarcoma cells to collagen
type II was mediated by the integrins a1b1 and a2b1 (24).
Since a1b1 is present on both chondrocytes (24) and fibro-
blasts (Fig. 5) and since this integrin appeared not to inter-
act with CHAD in the affinity chromatography experiments
(Figs. 4 and 5), it is unlikely that collagen contaminants in
the CHAD preparation were mediating the cell binding.
Since integrin a2b1 is also a receptor for collagen type II
(24) we asked whether adhesion to collagen type II and to
CHAD were mediated by similar mechanisms. One obser-
vation indicating that there is a difference in the a2b1 inte-
grin binding to these ligands is that chondrocytes (37),
T47D-cells (Fig. 10), and fibroblasts (data not shown) all
spread on immobilized collagen type II, while adhesion to
CHAD did not promote spreading. One explanation may
be that different sites on the a2 chain are involved in adhe-
sion to collagen type II and CHAD. To study this, we ad-
hered T47D cells to the two substrates in the presence of
various a2 antibodies. The monoclonal antibodies P1E6,
P1H5, and Gi9 are known to block adhesion of cells to col-
lagen. The monoclonal antibodies Gi19 and Gi29 have
some inhibitory effect on adhesion of platelets to collagen,
while Gi14 does not inhibit adhesion. (Santoso, S., per-
sonal communication) The T47D cells do not express col-
lagen type II binding integrins other than a2b1 and were
therefore particularly informative in these studies (45;
Camper, L., and E. Lundgren-Akerlund, unpublished re-
sults). We found that the different a2 antibodies inhibited
adhesion to collagen type II and CHAD in a similar man-
ner, indicating that these ligands bind to similar or nearby
sites on the a2b1 integrin (Fig. 9). Further experiments us-
ing a2 integrin antibodies recognizing other epitopes on
the a2 subunit will be needed to elucidate the binding
sites. Another explanation is that the binding of collagen
type II and CHAD is regulated differently. It has previ-
ously been shown that a2b1 integrins from different cell
types show different ligand specificity. a2b1 on platelets
and melanoma cells bind collagen (27, 46), while a2b1 on
other cell types binds both collagen and laminin (9, 30).
Several factors including divalent cations, proteoglycans,
and phospholipids have been suggested to modulate inte-
grin activity, and it has been suggested that the degree of
activation may regulate their ligand specificity (4). Since
Mn21 has been shown to increase the affinity between in-
tegrins and their ligands in affinity chromatography (13)
and cell adhesion (10, 32), we tested the possibility that
Mn21 could stimulate cell spreading. However, Mn21 ap-
peared not to stimulate spreading of T47D cells on immo-
bilized chondroadherin (data not shown). Phorbol esters
such as PMA are known to mimic the effect of several dif-
ferent integrin-activating stimuli and to induce clustering
of integrins (7, 42, 49). Protein kinase C may therefore be
an important regulator of the integrin affinity and ligand
specificity. Our finding that cells showed some spreading
on CHAD in the presence but not in the absence of PMA
(Fig. 10 and Table I) indicates that spreading of cells may
require activation and altered affinity of the integrins. It
also lends strong support to the involvement of integrins in
the cell attachment.
It is likely that integrin a2b1, being a receptor for two
different proteins in cartilage, has an important function in
mediating signals between the chondrocytes and the carti-
lage matrix. We and others (8, 24, 50) have found that iso-
lated chondrocytes express relatively small amounts of
a2b1 integrin. The collagen type II binding integrin a1b1,
on the other hand, is one of the major integrins on isolated
chondrocytes. It is possible that a2b1 is a more dynamic
integrin that is upregulated during changes in cell–matrix
interactions such as matrix turnover, remodelling, or me-
Table I. Spreading of T47D Cells on CII or CHAD in the 
Absence or in the Presence of PMA
CII CHAD
2 PMA 123 6 20 83 6 8
1 PMA 208 6 38 140 6 10
The numbers represent mean cell area (mm2) of cells 6 SD (n 5 4).The Journal of Cell Biology, Volume 138, 1997 1166
chanical stress. We have found that the integrin subunit a2
was upregulated in chondrosarcoma cells during mechani-
cal stress while the expression of a1 was not changed (24).
It has also been shown that the integrin subunit a2, but not
a1, is upregulated in fibroblasts in contracting collagen
gels (26, 40) during reorganization of the collagen matrix.
This supports the idea that the integrin a2b1 can respond
to changes in the extracellular matrix. Furthermore, it has
also been shown that growth factors such as TGFb (21)
and EGF (5) stimulate expression of the integrin a2b1, in-
dicating that growth factors can regulate the a2b1-medi-
ated interactions with the extracellular matrix. However,
further investigations are needed to understand the func-
tional role of the specific interaction of a2b1 with CHAD
in cartilage and to elucidate the differences between inter-
action of a2b1 with CHAD and collagen type II.
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